Health Care/Hospital

Ortoma Initiates Expansion With Module for Spine Surgery

STOCKHOLM, Nov. 8, 2019 /PRNewswire/ -- After a period of assessment of Ortoma's surgical system for hip surgery, the company is now taking the step next step and initiates expansion of Ortoma Treatment Solution (OTS) with a module also for spine surgery. -The conclusion after a number of perfor...

2019-11-08 21:40 6613

Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company

MADISON, Wisconsin, Nov. 8, 2019 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced that it has completed itspreviously announced combination with Genomic Health, Inc. (NASDAQ: GHDX). "Today marks a pivotal step toward building the world's leading advanced cancer diagnostics co...

2019-11-08 21:24 6875

Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial

Not intended for US, Canada and UK-based media  DARMSTADT, Germany, and NEW YORK, Nov. 8, 2019 /PRNewswire/ -- Merck and Pfizer Inc. (NYSE: PFE) today announced topline results of the Phase III JAVELIN Gastric 100 study evaluating avelumab as first-line maintenance therapy following induction ch...

2019-11-08 21:00 5954

SINOCHEM PHARMACEUTICAL Participated in CPhI Worldwide Europe

FRANKFURT, Germany, Nov. 8, 2019 /PRNewswire/ -- From November 5 to 7, 2019, CPhI Worldwide Europe was held in the Exhibition CentreFrankfurt, Germany. Dong Jianhua, executive director of Sinochem Pharmaceutical Co., Ltd., led a delegation to attend the exhibition. Sinochem Pharmaceutical has be...

2019-11-08 17:36 2660

Omega-3 Fatty-acid Enriched Parenteral Nutrition Improves Patient Outcomes

BAD HOMBURG, Germany, Nov. 8, 2019 /PRNewswire/ -- A new systematic literature review and meta-analysis[1] confirms and extends previous results that omega-3 (ω-3) fatty-acid enriched parenteral nutrition (PN) improves clinical outcomes compared with standard PN in adult patients. Including a tot...

2019-11-08 11:00 2563

Elmo Rietschle Oil-free Screw Technology Delivers Efficient Vacuum in the Healthcare Sector

SINGAPORE, Nov. 8, 2019 /PRNewswire/ -- As populations continue to grow, medical institutions around the world are faced with the challenge of efficiently managing resources to meet the growing demand for medical care and treatment. Byrecently partnering with pressure and vacuum experts like Gard...

2019-11-08 09:00 2977

Elmo Rietschle Oil-free Screw Technology Delivers Efficient Vacuum in the Healthcare Sector

MELBOURNE, Australia, Nov. 8, 2019 /PRNewswire/ -- As populations continue to grow, medical institutions around the world are faced with the challenge of efficiently managing resources to meet the growing demand for medical care and treatment. Byrecently partnering with pressure and vacuum expert...

2019-11-08 06:05 2481

Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost

PUNE, India, Nov. 7, 2019 /PRNewswire/ -- Enzene Biosciences today formally opened its first fully connected continuous Biologics manufacturing facility in Pune, India. This first-of-its-kind facility was built in half the time as compared to the conventional biologics manufacturing plants. The s...

2019-11-07 21:02 1612

TOT BIOPHARM (1875.HK) Proceeded with IPO raising over HK$500 million

HONG KONG, Nov. 7, 2019 /PRNewswire/ -- A clinical-stage biopharmaceutical company with full industry value chain capabilities, TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company", together with its subsidiaries, the "Group", stock code: 1875) was well received by the capi...

2019-11-07 19:04 6930

Bactiguard Holding AB (publ): Interim Report for Q3 2019

STOCKHOLM, Nov. 7, 2019 /PRNewswire/ -- The new license agreement with Zimmer Biomet contributed to that we delivered the strongest quarter to date for Bactiguard as a listed company. The partnership with one of the three largest orthopedic companies in the world confirms the strength of Bactigua...

2019-11-07 15:23 6499

FlexEnable Acquires Merck's OTFT Materials Portfolio for Flexible Displays

CAMBRIDGE, England, Nov. 7, 2019 /PRNewswire/ -- FlexEnable, the leader in the development and industrialisation of flexible organic electronics, has acquired Merck's portfolio of best-in-class, high-performance Organic Thin-Film Transistor (OTFT) materials, including revolutionary and highly-pat...

2019-11-07 12:00 1624

ASH 2019 | CStone's anti-PD-L1 antibody demonstrates a complete response rate of 31.8% in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma

SUZHOU, China, Nov. 7, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that an abstract on the CS1001-201 trial (Abstract #2833) was accepted by the 2019 American Society of Hematology (ASH) Annual Meeting and has been published online yesterday...

2019-11-07 11:02 2450

Medical Director of Amaris B. Clinic Shares Little-known Permanent Side Effects of Cryolipolysis (Fat Freezing Treatments)

SINGAPORE, Nov. 6, 2019 /PRNewswire/ -- Cryolipolysis, also known as Fat Freezing, is thriving as a non-invasive fat reduction treatment option in Singapore as with the rest of the world. It works by gently and efficiently targeting fat cells underneath the skin via targeted and controlled cool...

2019-11-07 09:42 1323

Johnson & Johnson and Lazada Group Enter Strategic Partnership

SHANGHAI, Nov. 7, 2019 /PRNewswire/ -- Johnson & Johnson Consumer Health ("Johnson & Johnson") and Lazada Group ("Lazada") today entered a strategic partnership to incubate more brands for success in Southeast Asian and Chinese markets. Qian...

2019-11-07 09:00 3577

First Asia-Pacific hospital treats patients with RayStation and Radixact

SUNNYVALE, California, Nov. 7, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) –Thailand's Lopburi Cancer Hospital, a center of excellence for cancer treatment, is the first in theAsia-Pacific region to clinically use the combination of RaySearch's treatment planning system RayStation® w...

2019-11-07 09:00 2674

AiCure Raises $24.5 Million Series C Round to Broaden Its Strategic Value for Life Sciences

NEW YORK, Nov. 7, 2019 /PRNewswire/ -- AiCure, recognized as one of the world's 100 most innovative artificial intelligence companies, announced a Series C fundraising round totaling$24.5 million. The financing was led by Palisades Growth Capital (PGC) with new investors from Singtel Innov8 (Inno...

2019-11-07 08:01 2026

Bioeq Announces Coherus as Marketing and Distribution Partner for Its Biosimilar to Lucentis® (ranibizumab) in the U.S.

- Bioeq agreement brings promise of their leading Lucentis® biosimilar for the treatment of retinopathies one step nearer for U.S. patients - ZÜRICH, Nov. 7, 2019 /PRNewswire/ -- Bioeq IP AG ("Bioeq") today announced that it signed a license and development agreement with Coherus BioSciences, In...

2019-11-07 05:14 2217

Antengene Corporation Announces Exclusive Worldwide License to Develop and Commercialize AZD0364

SHANGHAI and LONDON, Nov. 7, 2019 /PRNewswire/ -- Antengene Corporation today announced that it has entered into a licensing agreement with AstraZeneca (LSE/STO/NYSE: AZN) under which Antengene has been granted the exclusive global rights to further develop and commercialize AZD0364. Antengene Co...

2019-11-07 01:40 2525

Henlius HLX01 (Rituximab Injection) Wins "Biosimilar Initiative of the Year" at Global Generics & Biosimilars Awards 2019

SHANGHAI, Nov. 7, 2019 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), a leading biopharmaceutical company inChina focusing on oncology and autoimmune diseases, won the award of "Biosimilar Initiative of the Year" (HLX01, rituximab injection) and was also shortlisted for the award of "t...

2019-11-07 01:00 2550

EpiVax Announces Publication of Antigen-Specific Tolerance Induction by Tregitope in Nature Scientific Reports

PROVIDENCE, Rhode Island, Nov. 6, 2019 /PRNewswire/ -- EpiVax, Inc. ("EpiVax"), a pioneer in immunoinformatics innovation, announces the publication of "Therapeutic administration of Tregitope-Human Albumin Fusion with Insulin Peptides to promote Antigen-Specific Adaptive Tolerance Induction" inS...

2019-11-06 18:01 1660
1 ... 554555556557558559560 ... 566